Dalian BIO-CHEM Company Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	1,465	1,305	1,054	1,253	995.18	743.1
Other Revenue	6.83	6.83	11.3	3.32	11.08	6.44
Revenue	1,472	1,312	1,066	1,257	1,006	749.54
Revenue Growth (YoY)	32.55%	23.09%	-15.20%	24.88%	34.25%	-14.03%
Cost of Revenue	953.34	737.81	520.77	616.03	556.52	349.11
Gross Profit	518.48	573.89	544.89	640.63	449.74	400.43
Selling, General & Admin	154.24	111.16	120.52	132.2	91.52	111.09
Research & Development	67.38	49.65	38.98	47.09	40.02	28.57
Other Operating Expenses	7.45	10.92	10.37	14.93	9.17	9.31
Operating Expenses	223.6	178.98	168.44	195.05	144.8	146.34
Operating Income	294.88	394.91	376.44	445.58	304.93	254.09
Interest Expense	-23.6	-6.7	-3.92	-3.72	-11.77	-7.68
Interest & Investment Income	25.02	32.26	19.12	3.55	3.75	11
Currency Exchange Gain (Loss)	8.4	8.4	6.42	17.15	-0.47	-5.04
Other Non Operating Income (Expenses)	-22.36	-17.88	-13.69	-0.63	-0.89	-0.22
EBT Excluding Unusual Items	282.34	410.98	384.37	461.93	295.55	252.14
Gain (Loss) on Sale of Investments	-4.76	-	0.01	-7.57	0.59	1.03
Gain (Loss) on Sale of Assets	0.03	-	-	0.07	-	0.49
Asset Writedown	-0.7	-0.26	-0.11	-0.26	-0.97	-
Legal Settlements	-	-	-	-0.12	-10	-
Other Unusual Items	3.55	3.55	1.5	7.38	6.87	6.61
Pretax Income	280.45	414.27	385.78	461.43	292.04	260.27
Income Tax Expense	40.13	55.45	57.4	58.87	41.55	38.51
Earnings From Continuing Operations	240.32	358.82	328.38	402.57	250.49	221.75
Minority Interest in Earnings	-24.29	-13.57	-	-	-	-
Net Income	216.03	345.26	328.38	402.57	250.49	221.75
Net Income to Common	216.03	345.26	328.38	402.57	250.49	221.75
Net Income Growth	-27.91%	5.14%	-18.43%	60.71%	12.96%	-27.72%
Shares Outstanding (Basic)	702	711	697	692	687	716
Shares Outstanding (Diluted)	702	711	697	692	694	716
Shares Change (YoY)	-0.42%	2.04%	0.64%	-0.30%	-3.01%	-0.52%
EPS (Basic)	0.31	0.49	0.47	0.58	0.36	0.31
EPS (Diluted)	0.31	0.49	0.47	0.58	0.36	0.31
EPS Growth	-27.61%	3.03%	-18.95%	61.20%	16.46%	-27.35%
Free Cash Flow	63.52	88.07	322.33	345.62	-49.58	101.41
Free Cash Flow Per Share	0.09	0.12	0.46	0.50	-0.07	0.14
Dividend Per Share	0.429	0.429	0.306	0.292	-	0.219
Dividend Growth	40.02%	40.02%	4.97%	-	-	40.01%
Gross Margin	35.23%	43.75%	51.13%	50.98%	44.69%	53.42%
Operating Margin	20.04%	30.11%	35.33%	35.46%	30.30%	33.90%
Profit Margin	14.68%	26.32%	30.81%	32.04%	24.89%	29.59%
Free Cash Flow Margin	4.32%	6.71%	30.25%	27.50%	-4.93%	13.53%
EBITDA	367.44	463.65	440.08	516.59	353.15	296.57
EBITDA Margin	24.96%	35.35%	41.30%	41.11%	35.10%	39.57%
D&A For EBITDA	72.56	68.73	63.64	71.01	48.22	42.49
EBIT	294.88	394.91	376.44	445.58	304.93	254.09
EBIT Margin	20.04%	30.11%	35.33%	35.46%	30.30%	33.90%
Effective Tax Rate	14.31%	13.38%	14.88%	12.76%	14.23%	14.80%
Revenue as Reported	1,472	1,312	1,066	1,257	1,006	749.54
Advertising Expenses	-	0.22	0.65	0.14	0.03	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.